Elizabeth Crevier supports clients in conducting research and evaluating evidence on patient-centric care value and disease burden, often leveraging real-world data.

Before joining Avalere, Elizabeth conducted clinical research on type 1 diabetes at the Naomi Berrie Diabetes Center at New York Presbyterian Hospital. Previously, she served as associate director of a nonprofit providing low-income patients access to breast cancer care in New York City. She worked in translational research focused on autism spectrum disorder and chronic fatigue syndrome at the Center for Infection and Immunity, in market research focused on qualitative and mixed methods research, and in patient advocacy consulting as a scientific director.​

Elizabeth holds a bachelor’s degree in biology and neuroscience from Trinity College, and a Master of Public Health with a focus on epidemiology from Columbia University's Mailman School of Public Health.

Authored Content


Continued emphasis on diabetes management technology and patient-centered care in updated clinical management standards highlight the importance of advancing quality measurement.

In this installment of our 2024 Trends Influencing Rare Disease series, Avalere experts dive into patient centricity trends in rare disease.

Innovative research methods can be used to measure the total burden of rare disease, including direct medical costs, indirect costs, and overall life impacts.

In the next installment of our 2023 Top Trends in HEOR series, Avalere experts dive into Trend #7: Value Assessment.

Avalere identified the top trends in HEOR. In this Insight, Avalere experts dive into Trend #7: Value Assessment, and explore important considerations for stakeholders in utilizing this vital tool.